Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
262SP101(ION464-CS1)
Phase 1 other active
Quick answer
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON) for Multiple System Atrophy is a Phase 1 program (other) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Multiple System Atrophy
- Phase
- Phase 1
- Modality
- other
- Status
- active